Literature DB >> 14729940

Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization.

Eijiro Ozaki1, Haru Kato1, Hiroyuki Kita1, Tadahiro Karasawa1, Tsuneo Maegawa1, Youko Koino1, Kazumasa Matsumoto1, Toshihiko Takada1, Koji Nomoto1, Ryuichiro Tanaka1, Shinichi Nakamura1.   

Abstract

The aim of the present study was to investigate the colonization status of Clostridium difficile in healthy individuals. In total, 139 healthy adults from two study groups were examined at intervals of 3 months. Among the 18 positive subjects, the number of subjects from whom C. difficile was isolated once, twice, three times or four times was 10 (55.6%), three (16.7%), two (11.1%) and three (16.7%), respectively. In the student group, different subjects were colonized by different PCR ribotype/PFGE types. However, the same PCR ribotype/PFGE types of C. difficile were isolated from different subjects in the employee group, indicating that cross-transmission may have occurred in this group. Continuous colonization by the same PCR ribotype/PFGE type was only observed in three subjects. C. difficile-positive subjects were significantly more densely colonized by enterococci (P<0.05) than C. difficile-negative subjects: subjects that were found to be C. difficile-positive three or four times appeared to have higher concentrations of enterococci. The present results demonstrate that, although colonization by a C. difficile strain is transient in many cases, there are healthy individuals that are colonized persistently by C. difficile. They also suggest that dense colonization of the intestine by enterococci may be associated with C. difficile colonization.

Entities:  

Mesh:

Year:  2004        PMID: 14729940     DOI: 10.1099/jmm.0.05376-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  50 in total

Review 1.  Bacterial cell-to-cell signaling in the gastrointestinal tract.

Authors:  James B Kaper; Vanessa Sperandio
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 2.  Clostridium difficile in Food and Animals: A Comprehensive Review.

Authors:  C Rodriguez; B Taminiau; J Van Broeck; M Delmée; G Daube
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 3.  Infectious diarrhea: an overview.

Authors:  Brandon Dickinson; Christina M Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2014-08

4.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.

Authors:  Alison L Galdys; Jemma S Nelson; Kathleen A Shutt; Jessica L Schlackman; Diana L Pakstis; A William Pasculle; Jane W Marsh; Lee H Harrison; Scott R Curry
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

6.  Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection.

Authors:  Megan K Shaughnessy; Aleh Bobr; Michael A Kuskowski; Brian D Johnston; Michael J Sadowsky; Alexander Khoruts; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

7.  Letters to the editor.

Authors:  Matthew Clark
Journal:  Ochsner J       Date:  2014

Review 8.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

9.  Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.

Authors:  Kasper Krogh Andersen; Nika M Strokappe; Anna Hultberg; Kai Truusalu; Imbi Smidt; Raik-Hiio Mikelsaar; Marika Mikelsaar; Theo Verrips; Lennart Hammarström; Harold Marcotte
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

10.  Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Authors:  Rosanna Leuzzi; Janice Spencer; Anthony Buckley; Cecilia Brettoni; Manuele Martinelli; Lorenza Tulli; Sara Marchi; Enrico Luzzi; June Irvine; Denise Candlish; Daniele Veggi; Werner Pansegrau; Luigi Fiaschi; Silvana Savino; Erwin Swennen; Osman Cakici; Ernesto Oviedo-Orta; Monica Giraldi; Barbara Baudner; Nunzia D'Urzo; Domenico Maione; Marco Soriani; Rino Rappuoli; Mariagrazia Pizza; Gillian R Douce; Maria Scarselli
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.